Table 2.
Comparisons of Clinical Outcomes.
| Clinical Outcomes | Overall cohort | Propensity-matched cohort | ||||
|---|---|---|---|---|---|---|
| AT supplementation n = 45 | No AT supplementation n = 97 |
P-value | AT supplementation n = 34 |
No AT supplementation n = 34 |
P-value | |
| 28 day mortality | 8 (17.8) | 33 (34.0) | 0.047 | 8 (23.5) | 9 (26.5) | 0.786 |
| 90 day mortality | 16 (35.6) | 45 (48.4) | 0.155 | 14 (41.2) | 14 (41.2) | 0.754 |
| Recovery of organ function | 35 (77.8) | 68 (70.1) | 0.340 | 26 (76.5) | 27 (79.4) | 0.777 |
| Changes in SOFA score | 4.0 (2.0–7.0) | 4.0 (0.0–7.0) | 0.342 | 4.0 (2.0–7.0) | 5.0 (2.0–7.8) | 0.317 |
Data are shown as median (interquartile range) or as n (%).
Abbreviations: AT, antithrombin; SOFA, sequential organ failure assessment.